The future of brain-computer interfaces (BCIs) is shifting gears, with a new focus on cognitive disorders. While BCIs have already made remarkable strides in restoring movement and speech for those with paralysis, the next frontier lies in tackling the global burden of brain diseases, such as depression, anxiety, and PTSD. This shift requires a rethinking of BCI technology, moving away from decoding motor functions towards understanding and treating cognitive processes.
In a recent review published in Trends in Cognitive Sciences, Ignacio Saez, PhD, Director of the Laboratory for Human Neurophysiology at the Icahn School of Medicine, outlines a roadmap for developing next-generation cognitive BCIs. Saez argues that the key to success lies in recognizing the fundamental differences between decoding movement and cognition. While movement is represented in a stable, well-mapped area of the brain, cognition is a complex, dynamic process involving multiple brain regions and networks.
Saez emphasizes the need to merge BCI research, which has focused on reading the brain, with clinical neuromodulation, which has focused on stimulating it. This integration will create a closed-loop system that can detect dysfunctional brain states and respond with precise, adaptive neurostimulation. The building blocks for this system already exist, including intracranial brain recording, adaptive neurostimulation, and high-resolution neurochemical sensing.
The push towards cognitive BCIs is also fueled by growing commercial interest. Companies that have driven progress in motor and speech BCIs are now turning their attention to cognitive applications. The potential patient populations for cognitive BCIs are vast, addressing common psychiatric and neurological conditions. However, translating these advances from the lab to approved therapies will require close collaboration between academic researchers, clinicians, and industry.
Saez highlights the importance of building the necessary hardware, algorithms, and regulatory pathways for clinical-grade cognitive BCIs. This collaboration is crucial to ensure that the technology is safe, effective, and accessible to those who need it. As the field moves forward, the development of cognitive BCIs promises to revolutionize the treatment of brain disorders, offering a more personalized and precise approach to patient care.
